4.7 Article

Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow

Journal

BLOOD
Volume 125, Issue 16, Pages 2568-2578

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2014-09-599480

Keywords

-

Categories

Funding

  1. British Heart Foundation [FS/11/2/28579, PG/11/1/28461]
  2. National Health Service Grampian Endowment [14/43]
  3. Friends of Anchor
  4. Landsteiner Foundation for Blood Transfusion Research [1006]
  5. Cardiovascular Centre Maastricht
  6. British Society for Haemostasis and Thrombosis
  7. British Heart Foundation [FS/11/2/28579, PG/11/1/28461, PG/15/82/31721] Funding Source: researchfish

Ask authors/readers for more resources

The interaction of plasminogen with platelets and their localization during thrombus formation and fibrinolysis under flow are not defined. Using a novel model of whole blood thrombi, formed under flow, we examine dose-dependent fibrinolysis using fluorescence microscopy. Fibrinolysis was dependent upon flow and the balance between fibrin formation and plasminogen activation, with tissue plasminogen activator-mediated lysis being more efficient than urokinase plasminogen activator-mediated lysis. Fluorescently labeled plasminogen radiates from platelet aggregates at the base of thrombi, primarily in association with fibrin. Hirudin attenuates, but does not abolish plasminogen binding, denoting the importance of fibrin. Flow cytometry revealed that stimulation of platelets with thrombin/convulxin significantly increased the plasminogen signal associated with phosphatidylserine (PS)-exposing platelets. Binding was attenuated by tirofiban and Gly-Pro-Arg-Pro amide, confirming a role for fibrin in amplifying plasminogen binding to PSexposing platelets. Confocal microscopy revealed direct binding of plasminogen and fibrinogen to different platelet subpopulations. Binding of plasminogen and fibrinogen co-localized with PAC-1 in the center of spread platelets. In contrast, PS-exposing platelets were PAC-1 negative, and bound plasminogen and fibrinogen in a protruding cap. These data show that different subpopulations of platelets harbor plasminogen by diverse mechanisms and provide an essential scaffold for the accumulation of fibrinolytic proteins that mediate fibrinolysis under flow.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Biochemistry & Molecular Biology

Molecular Mechanisms of Hemostasis, Thrombosis and Thrombo-Inflammation

Marijke J. E. Kuijpers, Johan W. M. Heemskerk, Kerstin Jurk

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Hematology

Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)

Gael B. Morrow, Nicola J. Mutch

Summary: Plasminogen activator inhibitor 1 (PAI-1), a SERPIN inhibitor, is primarily known for its regulation of fibrinolysis. However, it is now known that this inhibitor functions and contributes to many (patho)physiological processes including inflammation, wound healing, cell adhesion, and tumor progression. This review discusses the past, present, and future roles of PAI-1, with a particular focus on the discovery of this inhibitor in the 1970s and subsequent characterization in health and disease.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2023)

Article Biochemistry & Molecular Biology

Cellular FXIII in Human Macrophage-Derived Foam Cells

Laura Somodi, Emoke Horvath, Helga Bardos, Barbara Barath, David Petho, Eva Katona, Jozsef Balla, Nicola J. Mutch, Laszlo Muszbek

Summary: Macrophages express FXIII-A, which cross-links proteins and may stabilize atherosclerotic plaque. These macrophages can become foam cells by accumulating oxLDL. FXIII-A is retained during the transformation into foam cells and its content increases. The presence of FXIII-A in the plaque suggests its involvement in plaque formation and structurization.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cell Biology

Atorvastatin-mediated inhibition of prenylation of Rab27b and Rap1a in platelets attenuates their prothrombotic capacity and modulates clot structure

Mohammed M. Jalal, Claire S. Whyte, Fraser P. Coxon, Nicola J. Mutch

Summary: In this study, it was found that atorvastatin (ATV) impairs the prenylation of Rab27b and Rap1a, leading to weakened platelet function. ATV delays clot formation and attenuates clot firmness, inhibits platelet aggregation and clot retraction, and reduces the binding of fibrinogen and P-selectin on activated platelets. Additionally, ATV affects the structure and stability of platelets and clots.

PLATELETS (2023)

Review Medicine, General & Internal

All tangled up: interactions of the fibrinolytic and innate immune systems

Claire S. S. Whyte

Summary: The hemostatic and innate immune system have intricate interactions. Inflammation in blood vessels promotes thrombus formation, while fibrin is involved in the innate immune response against invading pathogens. This interplay led to the introduction of the terms thromboinflammation and immunothrombosis. Once a thrombus forms, the fibrinolytic system is responsible for resolving and removing clots. Immune cells possess fibrinolytic regulators and plasmin, the central fibrinolytic enzyme, which also have diverse roles in immune regulation. This article discusses the intricate relationship between the fibrinolytic and innate immune system.

FRONTIERS IN MEDICINE (2023)

Editorial Material Cardiac & Cardiovascular Systems

Editorial: Women in thrombosis

Claire S. Whyte, Marina Panova-Noeva

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

Article Hematology

Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability

Joanne L. Mitchell, Gemma Little, Alexander P. Bye, Renato S. Gaspar, Amanda J. Unsworth, Neline Kriek, Tanya Sage, Alexander Stainer, Ibidayo Sangowawa, Gael B. Morrow, Ricardo N. Bastos, Susan Shapiro, Michael J. R. Desborough, Nicola Curry, Jonathan M. Gibbins, Claire S. Whyte, Nicola J. Mutch, Christopher I. Jones

Summary: This study identifies the role of platelet FXIII-A in platelet function. Platelet FXIII-A enhances fibrinogen binding to the platelet surface and improves platelet aggregation and thrombus formation. FXIII-A is also involved in platelet spreading and clot retraction.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2023)

Article Biochemistry & Molecular Biology

Regulation of Glycoprotein VI-Dependent Platelet Activation and Thrombus Formation by Heparan Sulfate Proteoglycan Perlecan

Isabella Provenzale, Ilaria De Simone, Jonathan M. Gibbins, Johan W. M. Heemskerk, Paola E. J. van der Meijden, Chris I. Jones

Summary: This study investigated the roles of different extracellular matrix proteoglycans in platelet responses and thrombus formation. It was found that one proteoglycan (perlecan) enhanced platelet activation and promoted thrombus formation, but also reduced platelet adhesion under flow. This suggests that proteoglycans play an important role in platelet activation and thrombus formation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Medicine, General & Internal

Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial

Pratima Chowdary, Banwari Agarwal, Maria Rita Peralta, Sanjay Bhagani, Simon Lee, James Goldring, Marc Lipman, Emal Waqif, Mark Phillips, Helen Philippou, Jonathan H. Foley, Nicola J. Mutch, Robert A. S. Ariens, Kathleen A. Stringer, Federico Ricciardi, Marie Watissee, Derralynn Hughes, Amit Nathwani, Anne Riddell, David Patch, Jim Buckley, Mark De Neef, Rahul Dimber, Cecilia Diaz-Garcia, Honey Patel, Aarti Nandani, Upuli Dissanayake, Nick Chadwick, Ahmed A. A. M. M. Alkhatip, Peter Watkinson, Eamon Raith, Suveer Singh, Tony Wolff, Rajeev Jha, Simon E. Brill, Ameet Bakhai, Alison Evans, Farhat Gilani, Keith Gomez

Summary: Nebulized recombinant tissue plasminogen activator (rt-PA) has the potential to improve lung injury and oxygenation in COVID-19 patients. Preliminary studies show better outcomes in patients receiving non-invasive respiratory support (NIRS). Randomized clinical trials are needed to confirm the clinical effects.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Novel therapeutics and emerging technology in haemostasis and thrombosis: highlights from the British society for haemostasis and thrombosis annual meeting

Claire S. Whyte, Gael B. Morrow, Julia S. Gauer, Samantha J. Montague, Philip L. R. Nicolson

Summary: The 2023 annual meeting of the British Society for Haemostasis and Thrombosis (BSHT) was held in Birmingham, United Kingdom, focusing on novel therapeutics and emerging technology. This article discusses the exciting research presented at the meeting.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

Article Hematology

Fibrinogenolysis and fibrinolysis in vaccine-induced immune thrombocytopenia and thrombosis

Megan Simpson, Anuj Narwal, Eric West, Jill Martin, Catherine N. Bagot, Andrew R. Page, Henry G. Watson, Claire S. Whyte, Nicola J. Mutch

Summary: This study found that VITT patients show evidence of overt disseminated intravascular coagulation and fibrinogenolysis, which is mediated by dysregulated plasmin generation. These findings are important for understanding the clinical features and mechanisms of VITT.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

Review Cardiac & Cardiovascular Systems

Platelet biology and function: plaque erosion vs. rupture

Constance C. F. M. J. Baaten, Magdolna Nagy, Wolfgang Bergmeier, Henri M. H. Spronk, Paola E. J. van der Meijden

Summary: Coronary atherosclerosis is the leading cause of heart disease in developed countries and is a chronic inflammatory process. The composition and location of atherosclerotic plaques determine the phenotype of the lesion, and plaque rupture or erosion can lead to acute clinical events. The contribution of platelets to thrombus formation differs depending on the plaque phenotype.

EUROPEAN HEART JOURNAL (2023)

No Data Available